Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 9/20 | 0.67 |
| ▸ | ITGA5 | P08648 | 3/20 | 0.67 |
| ▸ | ITGA4 | P13612 | 8/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | MMP2 | P08253 | 1/20 | 0.61 |
| ▸ | MMP9 | P14780 | 1/20 | 0.61 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.59 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.58 |
| ▸ | ITGAV | P06756 | 1/20 | 0.56 |
| ▸ | ITGB7 | P26010 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6710892 | 0.95 | ALDH1A1 (0.70) | ITGB1ITGA5ITGA4ALDH1A1MMP2 | |
| SCHEMBL6439213 | 0.95 | ALDH1A1 (0.70) | ITGB1ITGA5ITGA4ALDH1A1MMP2 | |
| SCHEMBL27514023 | 0.95 | ALDH1A1 (0.70) | ITGB1ITGA5ITGA4ALDH1A1MMP2 | |
| SCHEMBL7066469 | 0.95 | ALDH1A1 (0.70) | ITGB1ITGA5ITGA4ALDH1A1MMP2 | |
| SCHEMBL7069740 | 0.95 | ALDH1A1 (0.70) | ITGB1ITGA5ITGA4ALDH1A1MMP2 | |
| SCHEMBL7069752 | 0.92 | ALDH1A1 (0.69) | ITGB1ITGA5ITGA4ALDH1A1FKBP1A | |
| SCHEMBL7311830 | 0.91 | ITGB1 (0.60) | ITGB1ITGA5ITGA4ALDH1A1MMP2 | |
| SCHEMBL19235515 | 0.91 | ITGB1 (0.60) | ITGB1ITGA5ITGA4ALDH1A1MMP2 | |
| SCHEMBL6714530 | 0.91 | ITGA4 (0.66) | ITGB1ITGA5ITGA4ALDH1A1FKBP1A | |
| Methoxyamine SCHEMBL7553842 | 0.91 | ITGB1 (0.65) | ITGB1ITGA5ITGA4ALDH1A1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6492421-B1 | BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA | ATHENA NEUROSCIENCES, INC. | 2002-12-10 | — | — | US | claimed |
| EP-1001972-A1 | SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Elan Pharmaceuticals, Inc. (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1999006431-A1 | SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS, INC. (US) | 1999-02-11 | — | — | WO | claimed |
| US-6492421-B1 | BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA | ATHENA NEUROSCIENCES, INC. | 2002-12-10 | — | — | US | disclosed |
| CN-1265668-A | Substituted phenylalanine-type compounds that inhibit VLA-4 mediated leukocyte adhesion | ELAND PHARMACEUTICALS CO (US) | 2000-09-06 | — | — | CN | disclosed |
| EP-1001972-A1 | SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Elan Pharmaceuticals, Inc. (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999006431-A1 | SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS, INC. (US) | 1999-02-11 | — | — | WO | disclosed |